We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Therapeutic Effects of Equine-Assisted Psychotherapy (EAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04200612
Recruitment Status : Completed
First Posted : December 16, 2019
Last Update Posted : March 3, 2021
Sponsor:
Collaborators:
Nanyang Technological University
Therapeutic and Educational Riding in Singapore (THERIS)
Information provided by (Responsible Party):
Chua Yi Rong Shawn, National University of Singapore

Brief Summary:
Equine-assisted interventions (EAI) are an emerging form of alternate psychotherapy that has been increasingly found to produce improvements in various treatment outcomes. However, the paucity of randomized-controlled trials (RCTs) in the EAI literature prevents any definitive conclusions to be made about the general effectiveness of EAI. This study tests whether one form of EAI, Equine-Assisted Psychotherapy (EAP), reduces aggression and alters risk factors associated with aggression in young adults, and whether emotion regulation mediates any effect of EAP on aggression. In a single-blind RCT, undergraduate students will be randomly assigned to either an intervention group, an active-control group, or a placebo-control group. Participants in the intervention group will undergo a 5-week EAP program consisting of structured, interactive activities with horses followed by a clinical processing component. Participants in the active control group will undergo a 5-week program that only involves interactions with horses without any clinical input (i.e. commonly coined as animal-assisted activities). Participants in the placebo-control group will undergo 5 weeks of 1-hour movie sessions related to horses. There will be three waves of data collection measuring key outcome variables - t1 before the 1st session, t2 after the 3rd session, and t3 after the final session. Participants will complete questionnaires assessing the key outcomes of aggression, emotional well-being and academic performance. Other risk factors of antisocial behaviour such as psychopathy, level of empathy, emotion regulation and executive functioning will also be measured. To the author's knowledge, the current study is the first in Singapore to investigate if EAP can lower aggression levels and alter psychological risk factors for aggression in healthy young adults. In turn, these results could help inform the utility and validity of EAP in the forensic populations.

Condition or disease Intervention/treatment Phase
Aggression Stress Psychopathy Empathy Behavioral: Equine-Assisted Psychotherapy Behavioral: Equine-Assisted Activities Other: Placebo-control group Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 102 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: The design of the experiment will be a single-blind Randomized Controlled Trial. Participants are randomly assigned to either an intervention group, an active-control group or a placebo-control group. Participants in the intervention group will go through the 5-week EAP program consisting of the clinical processing following some activities found in EAP manuals. Participants in the active-control group will undergo a 5-week program that only involves interactions with horses without any clinical input (i.e. commonly coined as animal-assisted activities). Participants in the placebo-control group will undergo a 5-week movie screening of 1 hour each session that is related to horses in the lab.
Masking: Single (Participant)
Masking Description: Participants are informed that they will be randomly assigned to either a EAP horse interaction group or a EAP horse movie group. They are told that this study is meant to investigate the outcomes of two different types of EAP. In actuality, there are 3 groups in total - one intervention and two control groups. Participants in the intervention and active-control group will be told that they are in the EAP horse interaction group whereas participants in the placebo-control group are told that they are in the EAP horse movie group.
Primary Purpose: Other
Official Title: The Therapeutic Effects of Equine-Assisted Psychotherapy on Lowering Aggression Levels Through an Increase of Emotion Regulation
Actual Study Start Date : January 20, 2020
Actual Primary Completion Date : April 9, 2020
Actual Study Completion Date : November 6, 2020

Arm Intervention/treatment
Experimental: Intervention Group
Participants in the intervention group will go through the 5-week EAP program consisting of the clinical processing following some activities found in EAP manuals.
Behavioral: Equine-Assisted Psychotherapy
Equine-Assisted Psychotherapy (EAP) involves working on the psychological goals set between the client and the mental health professional. This is done through the experiential interactions between the clients and the horse. This experiential aspect is vital as it allows clients to process the emotions, thoughts and behaviors that were expressed during sessions with the horse.
Other Name: Equine-Facilitated Psychotherapy

Behavioral: Equine-Assisted Activities
Simple interactions with the horses that does not necessarily involve any goals being set between the client and the personnel handling the session. These can involve activities such as grooming or petting of the horse.

Active Comparator: Active-control group
Participants in the active-control group will undergo a 5-week program that only involves interactions with horses without any clinical input (i.e. commonly coined as animal-assisted activities).
Behavioral: Equine-Assisted Activities
Simple interactions with the horses that does not necessarily involve any goals being set between the client and the personnel handling the session. These can involve activities such as grooming or petting of the horse.

Placebo Comparator: Placebo-control group
Participants in the placebo-control group will undergo a 5-week movie screening of 1 hour each session that is related to horses.
Other: Placebo-control group
This group will only be watching movies related to horses and they are told that this is another form of EAP even though this is not the case. This type of intervention has not been known to provide any therapeutic effect relevant to the study and thus is used as the placebo-control.




Primary Outcome Measures :
  1. Young Adult Behavioral Scale (YABS) [ Time Frame: Immediately before the 1st intervention session ]
    Min. Value: 1 (never), Max. Value: 5 (always), higher scores indicate a higher likelihood in the domains of relational aggression, social aggression and interpersonal maturity.

  2. Young Adult Behavioral Scale (YABS) [ Time Frame: Immediately after the 3rd intervention session ]
    Min. Value: 1 (never), Max. Value: 5 (always), higher scores indicate a higher likelihood in the domains of relational aggression, social aggression and interpersonal maturity.

  3. Young Adult Behavioral Scale (YABS) [ Time Frame: Immediately after the 5th intervention session ]
    Min. Value: 1 (never), Max. Value: 5 (always), higher scores indicate a higher likelihood in the domains of relational aggression, social aggression and interpersonal maturity.

  4. Reactive-Proactive Aggression Questionnaire (RPQ) [ Time Frame: Immediately before the 1st intervention session ]
    Min. Value: 0 (never), Max. Value: 2 (often), higher scores indicate higher general aggression levels

  5. Reactive-Proactive Aggression Questionnaire (RPQ) [ Time Frame: Immediately after the 3rd intervention session ]
    Min. Value: 0 (never), Max. Value: 2 (often), higher scores indicate higher general aggression levels

  6. Reactive-Proactive Aggression Questionnaire (RPQ) [ Time Frame: Immediately after the 5th intervention session ]
    Min. Value: 0 (never), Max. Value: 2 (often), higher scores indicate higher general aggression levels

  7. Depression Anxiety Stress Scale - 21 items (DASS-21) [ Time Frame: Immediately before the 1st intervention session ]
    Min. Value: 0 (did not apply to me at all), Max. Value: 3 (applied to me very much, or most of the time), higher scores indicate poorer emotional well-being

  8. Depression Anxiety Stress Scale - 21 items (DASS-21) [ Time Frame: Immediately after the 3rd intervention session ]
    Min. Value: 0 (did not apply to me at all), Max. Value: 3 (applied to me very much, or most of the time), higher scores indicate poorer emotional well-being

  9. Depression Anxiety Stress Scale - 21 items (DASS-21) [ Time Frame: Immediately after the 5th intervention session ]
    Min. Value: 0 (did not apply to me at all), Max. Value: 3 (applied to me very much, or most of the time), higher scores indicate poorer emotional well-being

  10. Motivated strategies for Learning Questionnaire (MSLQ) [ Time Frame: Immediately before the 1st intervention session ]
    Min. Value: 1 (not at all true of me), Max. Value: 7 (very true of me), higher scores indicate greater motivations to learn using the different strategies

  11. Motivated strategies for Learning Questionnaire (MSLQ) [ Time Frame: Immediately after the 3rd intervention session ]
    Min. Value: 1 (not at all true of me), Max. Value: 7 (very true of me), higher scores indicate greater motivations to learn using the different strategies

  12. Motivated strategies for Learning Questionnaire (MSLQ) [ Time Frame: Immediately after the 5th intervention session ]
    Min. Value: 1 (not at all true of me), Max. Value: 7 (very true of me), higher scores indicate greater motivations to learn using the different strategies

  13. Emotion Regulation Questionnaire (ERQ) [ Time Frame: Immediately before the 1st intervention session ]
    Min. Value: 1 (strongly disagree), Max. Value: 7 (strongly agree), higher scores indicate greater likelihood of using the two types of emotion regulation strategies

  14. Emotion Regulation Questionnaire (ERQ) [ Time Frame: Immediately after the 3rd intervention session ]
    Min. Value: 1 (strongly disagree), Max. Value: 7 (strongly agree), higher scores indicate greater likelihood of using the two types of emotion regulation strategies

  15. Emotion Regulation Questionnaire (ERQ) [ Time Frame: Immediately after the 5th intervention session ]
    Min. Value: 1 (strongly disagree), Max. Value: 7 (strongly agree), higher scores indicate greater likelihood of using the two types of emotion regulation strategies

  16. Difficulties in Emotion Regulation Scale - Short Form (DERS-SF) [ Time Frame: Immediately before the 1st intervention session ]
    Min. Value: 1 (almost never), Max. Value: 5 (almost always), higher scores indicate greater difficulties with emotion regulation

  17. Difficulties in Emotion Regulation Scale - Short Form (DERS-SF) [ Time Frame: Immediately after the 3rd intervention session ]
    Min. Value: 1 (almost never), Max. Value: 5 (almost always), higher scores indicate greater difficulties with emotion regulation

  18. Difficulties in Emotion Regulation Scale - Short Form (DERS-SF) [ Time Frame: Immediately after the 5th intervention session ]
    Min. Value: 1 (almost never), Max. Value: 5 (almost always), higher scores indicate greater difficulties with emotion regulation


Secondary Outcome Measures :
  1. Self-Report Psychotherapy - Short Form (SRP-SF) [ Time Frame: Immediately before the 1st intervention session ]
    Min. Value: 1 (strongly disagree), Max. Value: 5 (strongly agree), higher scores indicate higher levels of psychopathy

  2. Self-Report Psychotherapy - Short Form (SRP-SF) [ Time Frame: Immediately after the 3rd intervention session ]
    Min. Value: 1 (strongly disagree), Max. Value: 5 (strongly agree), higher scores indicate higher levels of psychopathy

  3. Self-Report Psychotherapy - Short Form (SRP-SF) [ Time Frame: Immediately after the 5th intervention session ]
    Min. Value: 1 (strongly disagree), Max. Value: 5 (strongly agree), higher scores indicate higher levels of psychopathy

  4. Cognitive, Affective and Somatic Empathy Scales (CASES) [ Time Frame: Immediately before the 1st intervention session ]
    Min. Value: 0 (rarely), Max. Value: 2 (often), higher scores indicate higher levels of empathy

  5. Cognitive, Affective and Somatic Empathy Scales (CASES) [ Time Frame: Immediately after the 3rd intervention session ]
    Min. Value: 0 (rarely), Max. Value: 2 (often), higher scores indicate higher levels of empathy

  6. Cognitive, Affective and Somatic Empathy Scales (CASES) [ Time Frame: Immediately after the 5th intervention session ]
    Min. Value: 0 (rarely), Max. Value: 2 (often), higher scores indicate higher levels of empathy

  7. Trail Making Task - Part B (TMT - Part B) [ Time Frame: Immediately before the 1st intervention session ]
    Unit of measure: Reaction Time (s), higher scores indicate higher levels of executive functioning, more specific to attention span and attentional task switching abilities

  8. Trail Making Task - Part B (TMT - Part B) [ Time Frame: Immediately after the 3rd intervention session ]
    Unit of measure: Reaction Time (s), higher scores indicate higher levels of executive functioning, more specific to attention span and attentional task switching abilities

  9. Trail Making Task - Part B (TMT - Part B) [ Time Frame: Immediately after the 5th intervention session ]
    Unit of measure: Reaction Time (s), higher scores indicate higher levels of executive functioning, more specific to attention span and attentional task switching abilities



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 28 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Do not have any medical allergies or discomfort from interaction with horses.

Exclusion Criteria:

  • Participants who self-report an existing diagnosis for a psychological disorder as defined by the Diagnostic and Statistical Manual of Mental Disorders, 5th edition: DSM-V

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04200612


Locations
Layout table for location information
Singapore
Therapeutic and Educational Riding in Singapore
Singapore, Singapore, 286965
Sponsors and Collaborators
Chua Yi Rong Shawn
Nanyang Technological University
Therapeutic and Educational Riding in Singapore (THERIS)
Investigators
Layout table for investigator information
Principal Investigator: Olivia Choy, PhD Nanyang Technological University
Principal Investigator: Lim SM Matthew, PhD, PsyD National University of Singapore
Layout table for additonal information
Responsible Party: Chua Yi Rong Shawn, Co-Investigator, National University of Singapore
ClinicalTrials.gov Identifier: NCT04200612    
Other Study ID Numbers: S-19-357
First Posted: December 16, 2019    Key Record Dates
Last Update Posted: March 3, 2021
Last Verified: March 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: There is no plans for such sharing as of now.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Chua Yi Rong Shawn, National University of Singapore:
Equine-Assisted Psychotherapy
Emotion Regulation
Aggression
Outcomes
Randomized-Controlled Trials
Additional relevant MeSH terms:
Layout table for MeSH terms
Aggression
Behavioral Symptoms